ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO1037

Increased Risk of Middle Cerebral Artery Aneurysms in Postmenopausal Women with ADPKD: Insights from Attribute-Based Medicine (ABM) with Cross-Classification Based on Sex and Age

Session Information

Category: Women's Health and Kidney Diseases

  • 2200 Women's Health and Kidney Diseases

Authors

  • Kataoka, Hiroshi, Tokyo Joshi Ika Daigaku, Shinjuku, Tokyo, Japan
  • Mochizuki, Toshio, Tokyo Joshi Ika Daigaku, Shinjuku, Tokyo, Japan
  • Manabe, Shun, Tokyo Joshi Ika Daigaku, Shinjuku, Tokyo, Japan
  • Ushio, Yusuke, Tokyo Joshi Ika Daigaku, Shinjuku, Tokyo, Japan
  • Tsuchiya, Ken, Tokyo Joshi Ika Daigaku, Shinjuku, Tokyo, Japan
  • Nitta, Kosaku, Tokyo Joshi Ika Daigaku, Shinjuku, Tokyo, Japan
  • Hoshino, Junichi, Tokyo Joshi Ika Daigaku, Shinjuku, Tokyo, Japan
Background

The 2024 KDIGO conference emphasized shifting away from a one-size-fits-all model toward individualized CKD care. Women with autosomal dominant polycystic kidney disease (ADPKD) face a heightened risk of intracranial aneurysms (IAs), yet the role of menopause-related hormonal changes in IA susceptibility remains underexplored. Given the global burden of aneurysmal subarachnoid hemorrhage (SAH) and the known impact of estrogen decline on vascular integrity, understanding sex- and age-specific IA risk is essential to improving care for women with ADPKD.

Methods

We retrospectively analyzed 519 ADPKD outpatients who underwent MRA screening at a single Japanese center. Patients were cross-classified by sex and age (<50 vs ≥50 years) to assess IA prevalence, rupture history, and aneurysm location. Multivariable logistic regression and Kaplan–Meier analyses identified IA risk factors. Special focus was placed on middle cerebral artery (MCA) aneurysms using a cross-classification approach.

Results

IA prevalence was highest in women ≥50 years (31.3%), compared to 19.4% in all women and 16.6% in men. Female sex, advanced CKD (stages IV–V), hypertension, and a family history of IA/SAH emerged as independent risk factors. Notably, women ≥50 years had a tenfold higher risk of MCA aneurysms than women <50 years (40.5% vs 5.9%, OR=10.88, P=0.011). Logistic regression confirmed women ≥50 years as an independent risk group for both IAs (OR=2.11, P=0.006) and MCA aneurysms (OR=4.22, P<0.001). Time-to-event analysis revealed earlier IA development in this subgroup, especially among hypertensive patients.

Conclusion

Women ≥50 years with ADPKD represent a high-risk group for intracranial and MCA aneurysms. These findings underscore the importance of menopause-aware screening and prevention strategies. Hormonal and vascular factors likely contribute to IA vulnerability in this group, supporting tailored surveillance protocols to improve cerebrovascular outcomes in women with ADPKD.

Attribute-Based Cross-Classification by Sex and Age for Intracranial and MCA Aneurysms in ADPKD

Digital Object Identifier (DOI)